Exact Mass: 362.07817800000004
Exact Mass Matches: 362.07817800000004
Found 49 metabolites which its exact mass value is equals to given mass value 362.07817800000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methyl 18-Bromo-(17Z)-octadeca-17-ene-5,7,15-triynoate
Methyl 18-Bromo-(9Z,15Z,17E)-octadeca-9,15,17-triene-5,7-diynoate
5-(4,4,6-trimethyl-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)naphthalene-2-sulfonic acid
Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate
Methyl 18-bromo-9E,15E,17E-octadecatrien-5,7-diynoate
7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
C18H16ClFN2O3 (362.08334279999997)
4-[3-(3,4-dicyanophenoxy)phenoxy]benzene-1,2-dicarbonitrile
C22H10N4O2 (362.08037199999995)
4-BENZYLOXY-5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)-PYRIMIDINE
C16H19BrN4O (362.07421439999996)
Piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate
(R)-3-((6,7,8,9-TETRAHYDRO-5H-BENZO[7]ANNULEN-5-YL)THIO)-5-UREIDOISOTHIAZOLE-4-CARBOXAMIDE
Trimethyl[1-(2,6-xylylcarbamoyl)ethyl]ammonium iodide
C14H23IN2O (362.08550579999996)
4-(dimethylsulfamoyl)-N-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]benzamide
C15H14N4O5S (362.06848740000004)
1,5-Dihydroxy-4,8-bis(hydroxy(hydroxymethyl)amino)anthraquinone
6-(1,3-benzodioxol-5-yl)-N-(2-thiazolylmethyl)-4-quinazolinamine
4-chloro-N-[4-[3-(methylthio)anilino]-4-oxobutyl]benzamide
2-[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]-N-phenylacetamide
3-[(1,3-benzothiazol-2-ylthio)methyl]-4-cyclohexyl-1H-1,2,4-triazole-5-thione
C16H18N4S3 (362.06935480000004)
8-Chloro-7-[2-(4-methoxyphenyl)-2-oxoethyl]-1,3-dimethylpurine-2,6-dione
C16H15ClN4O4 (362.07817800000004)
Cefadroxil(1-)
A cephalosporin carboxylic acid anion having a 7beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino side-chain, formed by proton loss from the carboxy group of the cephalosporin cefadroxil.
BZAD-01
C16H12F6N2O (362.08537739999997)
BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation[1].
ZINC00784494
C20H14N2O3S (362.07250940000006)
ZINC00784494 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00784494 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00784494 has good potential for research in inflammatory breast cancer (IBC)[1].
methyl (9z,15z,17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate
methyl (17e)-18-bromooctadeca-9,15,17-trien-5,7-diynoate
methyl (17e)-18-bromooctadec-17-en-5,7,15-triynoate
methyl 2-(4-hydroxy-3-{[2-hydroxy-5-(2-methoxy-2-oxoethyl)phenyl]sulfanyl}phenyl)acetate
C18H18O6S (362.08240480000006)